US Stock MarketDetailed Quotes

AbCellera Biologics (ABCL)

Watchlist
  • 3.745
  • +0.035+0.94%
Trading Mar 4 11:02 ET
1.14BMarket Cap-7.64P/E (TTM)

AbCellera Biologics (ABCL) Key Financial Indicators

ABCL Earnings per Share (EPS)

According to the latest financial report of AbCellera Biologics, the latest earnings per share (TTM) for the company is -0.03. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

ABCL Free Cash Flow (FCF)

Interested in knowing about AbCellera Biologics's free cash flow? The latest report shows it as -44.59M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

ABCL Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of AbCellera Biologics shows that the company's current ratio is 11.32, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

ABCL Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of AbCellera Biologics, the quick ratio is 10.69, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

ABCL Return on Equity (ROE)

Want to learn more about the financial health of AbCellera Biologics? The latest ROE figure is -0.93%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

ABCL Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of AbCellera Biologics, the total asset return on investment (ROA) is -0.66%.

Currency: USD

Quarterly

Loading...

ABCL Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check AbCellera Biologics's latest financial report to see how their gross margin is doing - currently at 92.79%.

Currency: USD

Quarterly

Loading...

ABCL Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of AbCellera Biologics, the net profit margin is -19.94%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More